International Clinical Trial: The FLIP-IT trial - Fully automated artificial pancreas in adults with previously above-target type 1 diabetes

Geneva, Aug. 5 -- International Clinical Trials Registry received information related to the study (ACTRN12625000762459) titled 'The FLIP-IT trial - Fully automated artificial pancreas in adults with previously above-target type 1 diabetes' on July 18.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial Masking: Open (masking not used) Assignment: Other Type of endpoint: Safety/efficacy

Primary Sponsor: University of Otago

Condition: Type 1 diabetes Type 1 diabetes Metabolic and Endocrine - Diabetes

Intervention: This is an, open-label three-phase study. Expected duration of total participant study participation is 41 weeks (including 2 weeks of baseline data collection). Phase 1 is ...